Pacira BioSciences

Pacira BioSciences is a holding company. Through its subsidiaries, the company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its proprietary DepoFoam? extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. The company's marketed product, EXPAREL (bupivacaine liposome injectable suspension) is indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. EXPAREL consists of bupivacaine, an amide-type local anesthetic, encapsulated in DepoFoam, the company's proprietary technology that delivers bupivacaine over time for extended analgesia.
  • TickerPCRX
  • ISINUS6951271005
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

Liana Moussatos ...
  • Shveta Dighe

Q1; EXPAREL® Sales Miss; We Anticipate Sales Acceleration in 2019

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

Liana Moussatos ...
  • Shveta Dighe

Q1; EXPAREL® Sales Miss; We Anticipate Sales Acceleration in 2019

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ValuEngine Rating and Forecast Report for PCRX

ResearchPool Subscriptions

Get the most out of your insights

Get in touch